1 Study Coverage
1.1 Respiratory Syncytial Virus (RSV) Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Respiratory Syncytial Virus (RSV) Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size Growth Rate by Type
1.4.2 Palivizumab
1.4.3 Ribavirin
1.4.4 Others
1.5 Market by Application
1.5.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue 2015-2026
2.1.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Sales 2015-2026
2.2 Global Respiratory Syncytial Virus (RSV) Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Respiratory Syncytial Virus (RSV) Therapeutics Competitor Landscape by Players
3.1 Respiratory Syncytial Virus (RSV) Therapeutics Sales by Manufacturers
3.1.1 Respiratory Syncytial Virus (RSV) Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Respiratory Syncytial Virus (RSV) Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Manufacturers
3.2.1 Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Respiratory Syncytial Virus (RSV) Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus (RSV) Therapeutics Revenue in 2019
3.2.5 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Respiratory Syncytial Virus (RSV) Therapeutics Price by Manufacturers
3.4 Respiratory Syncytial Virus (RSV) Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Respiratory Syncytial Virus (RSV) Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Respiratory Syncytial Virus (RSV) Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Respiratory Syncytial Virus (RSV) Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Sales by Type (2015-2020)
4.1.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Type (2015-2020)
4.1.3 Respiratory Syncytial Virus (RSV) Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Respiratory Syncytial Virus (RSV) Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Sales by Application (2015-2020)
5.1.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Application (2015-2020)
5.1.3 Respiratory Syncytial Virus (RSV) Therapeutics Price by Application (2015-2020)
5.2 Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Respiratory Syncytial Virus (RSV) Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Respiratory Syncytial Virus (RSV) Therapeutics by Country
6.1.1 North America Respiratory Syncytial Virus (RSV) Therapeutics Sales by Country
6.1.2 North America Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Type
6.3 North America Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Respiratory Syncytial Virus (RSV) Therapeutics by Country
7.1.1 Europe Respiratory Syncytial Virus (RSV) Therapeutics Sales by Country
7.1.2 Europe Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Type
7.3 Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics by Region
8.1.1 Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Sales by Region
8.1.2 Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Respiratory Syncytial Virus (RSV) Therapeutics by Country
9.1.1 Latin America Respiratory Syncytial Virus (RSV) Therapeutics Sales by Country
9.1.2 Latin America Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Type
9.3 Central & South America Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Respiratory Syncytial Virus (RSV) Therapeutics by Country
10.1.1 Middle East and Africa Respiratory Syncytial Virus (RSV) Therapeutics Sales by Country
10.1.2 Middle East and Africa Respiratory Syncytial Virus (RSV) Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Respiratory Syncytial Virus (RSV) Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.1.5 Roche Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.3.5 Merck Related Developments
11.4 AbbVie
11.4.1 AbbVie Corporation Information
11.4.2 AbbVie Description and Business Overview
11.4.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.4.4 AbbVie Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.4.5 AbbVie Related Developments
11.5 Bausch Health
11.5.1 Bausch Health Corporation Information
11.5.2 Bausch Health Description and Business Overview
11.5.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bausch Health Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.5.5 Bausch Health Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 ReViral
11.7.1 ReViral Corporation Information
11.7.2 ReViral Description and Business Overview
11.7.3 ReViral Sales, Revenue and Gross Margin (2015-2020)
11.7.4 ReViral Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.7.5 ReViral Related Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Corporation Information
11.8.2 Gilead Sciences Description and Business Overview
11.8.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Gilead Sciences Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.8.5 Gilead Sciences Related Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Corporation Information
11.9.2 Teva Pharmaceutical Description and Business Overview
11.9.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.9.5 Teva Pharmaceutical Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Respiratory Syncytial Virus (RSV) Therapeutics Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Respiratory Syncytial Virus (RSV) Therapeutics Market Estimates and Projections by Region
12.1.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Respiratory Syncytial Virus (RSV) Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Respiratory Syncytial Virus (RSV) Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Respiratory Syncytial Virus (RSV) Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Respiratory Syncytial Virus (RSV) Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Respiratory Syncytial Virus (RSV) Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Respiratory Syncytial Virus (RSV) Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Respiratory Syncytial Virus (RSV) Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Respiratory Syncytial Virus (RSV) Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Respiratory Syncytial Virus (RSV) Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Respiratory Syncytial Virus (RSV) Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Respiratory Syncytial Virus (RSV) Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Respiratory Syncytial Virus (RSV) Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Respiratory Syncytial Virus (RSV) Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Roche、AstraZeneca、Merck、AbbVie、Bausch Health、GlaxoSmithKline、ReViral、Gilead Sciences、Teva Pharmaceutical
【免責事項】
https://www.globalresearch.jp/disclaimer